How much funding has MapLight Therapeutics raised?

MapLight Therapeutics has raised $372.5M in total funding, most recently a Series D round.

Who are MapLight Therapeutics's investors?

MapLight Therapeutics's investors include Forbion Capital Partners, Novo Holdings A/S.

When was MapLight Therapeutics founded?

MapLight Therapeutics was founded in 2018.

Where is MapLight Therapeutics headquartered?

MapLight Therapeutics is headquartered in San Francisco, California, United States.

What industry is MapLight Therapeutics in?

MapLight Therapeutics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does MapLight Therapeutics have?

MapLight Therapeutics has 51-200 employees.

MapLight Therapeutics

IPO

Creating breakthrough innovative therapeutics for serious CNS disorders

Public · San Francisco, United States · Founded 2018 · $372.5M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 51–200
Founded: 2018
Business Model: Other
Website: maplighttx.com

Total Funding: $372.5M
Last Round: $372.5M Series DJul 2025
Rounds: 1
Type: Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for central nervous system (CNS) disorders using an integrated computational and experimental platform.

Summary

MapLight Therapeutics is an Artificial Intelligence company based in San Francisco, United States, founded in 2018. It has raised $372.5M in total across 1 round, most recently a $372.5M Series D round in Jul 2025. Investors include Forbion Capital Partners and Novo Holdings A/S.

LinkedIn X (Twitter)GitHub

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOOct 2025

$258.9M

Oct 2025

Sign up to see all 2 events

Funding: Series D. Amounts, valuations, and investors where available.

Investors

Forbion Capital Partners

Lead

1 round

Novo Holdings A/S

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth EquityTotal funding$5.1BAug 2022

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare

Private EquityTotal funding$3.9BJan 2019

Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare

Series FTotal funding$3.8BJan 2026

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private EquityTotal funding$3.0BJan 2004

Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare

Corporate RoundTotal funding$3.0BMar 2026

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/maplight-therapeutics"><img src="https://indexed.vc/api/badge/company/maplight-therapeutics" alt="MapLight Therapeutics on Indexed.vc" width="260" height="76" /></a>